Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Consensus price target: $4.00 (+3569.72% upside from $0.11)
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $22.54M | -39.15% | $-27.28M |
| 2024 | $37.04M | +17.74% | $12.45M |
| 2023 | $31.46M | -10.35% | $10.55M |
Stock data for BDMD: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics